The company has seen one positive revision in the past one month, while its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for this industry stock. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Proteon Therapeutics currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is negative.
A better-ranked stock in the same industry is Affymetrix Inc. (AFFX), sporting a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment